BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lai JC, Covinsky KE, Dodge JL, Boscardin WJ, Segev DL, Roberts JP, Feng S. Development of a novel frailty index to predict mortality in patients with end-stage liver disease. Hepatology 2017;66:564-74. [PMID: 28422306 DOI: 10.1002/hep.29219] [Cited by in Crossref: 254] [Cited by in F6Publishing: 204] [Article Influence: 42.3] [Reference Citation Analysis]
Number Citing Articles
1 Faulkes RE, Rehman Z, Palanichamy S, Zakeri N, Coldham C, Dasari BVM, Perera MTPR, Rajoriya N, Shetty S, Shah T. Comparable Overall Survival in Patients with Hepatocellular Carcinoma Diagnosed within and Outside a Surveillance Programme: The Potential Impact of Liver Cirrhosis. Cancers 2023;15:978. [DOI: 10.3390/cancers15030978] [Reference Citation Analysis]
2 Bowers SP, Brennan PN, Dillon JF. Systematic review: the role of frailty in advanced chronic liver disease. Aliment Pharmacol Ther 2023;57:280-9. [PMID: 36433627 DOI: 10.1111/apt.17324] [Reference Citation Analysis]
3 Thuluvath AJ, Siddiqui O, Lai JC, Peipert J, Levitsky J, Daud A, Mazumder NR, Flores AM, Borja-Cacho D, Caicedo JC, Loftus C, Wong R, Mroczek D, Ladner DP. Personality Traits in Patients With Cirrhosis Are Different From Those of the General Population and Impact Likelihood of Liver Transplantation. Transplantation 2023;107:420-8. [PMID: 36173424 DOI: 10.1097/TP.0000000000004304] [Reference Citation Analysis]
4 Meena BL, Taneja S, Tandon P, Sahni N, Soundararajan R, Gorsi U, De A, Verma N, Premkumar M, Duseja A, Dhiman RK, Singh V. Home-based intensive nutrition therapy improves frailty and sarcopenia in patients with decompensated cirrhosis: A randomized clinical trial. J Gastroenterol Hepatol 2023;38:210-8. [PMID: 36268614 DOI: 10.1111/jgh.16035] [Reference Citation Analysis]
5 Barritt Iv AS. Measurements matter: Assessing outcomes in "lean" patients with nonalcoholic fatty liver disease awaiting liver transplantation. Liver Transpl 2023;29:128-9. [PMID: 36177548 DOI: 10.1002/lt.26579] [Reference Citation Analysis]
6 Becchetti C, Lange NF, Delgado MG, Brönnimann MP, Maurer MH, Dufour JF, Berzigotti A. 2D shear wave elastography of the rectus femoris muscle in patients with cirrhosis: Feasibility and clinical findings. A pilot study. Clin Res Hepatol Gastroenterol 2023;47:102080. [PMID: 36657524 DOI: 10.1016/j.clinre.2023.102080] [Reference Citation Analysis]
7 Holman A, Parikh N, Clauw DJ, Williams DA, Tapper EB. Contemporary management of pain in cirrhosis: Toward precision therapy for pain. Hepatology 2023;77:290-304. [PMID: 35665522 DOI: 10.1002/hep.32598] [Reference Citation Analysis]
8 Cesari M, Azzolino D. Frailty. Geriatric Medicine 2023. [DOI: 10.1007/978-3-030-01782-8_112-1] [Reference Citation Analysis]
9 Warner Ii ER, Satapathy SK. Sarcopenia in the Cirrhotic Patient: Current Knowledge and Future Directions. J Clin Exp Hepatol 2023;13:162-77. [PMID: 36647414 DOI: 10.1016/j.jceh.2022.06.005] [Reference Citation Analysis]
10 Towey J, Ngonadi C, Rajoriya N, Holt A, Greig C, Armstrong MJ. Protocol for a case-control prospective study to investigate the impact of Hepatic Encephalopathy on Nutritional Intake and Sarcopenia status in patients with end-stage LIVer disease: HENS-LIV study. BMJ Open Gastroenterol 2022;9. [PMID: 36564096 DOI: 10.1136/bmjgast-2022-001052] [Reference Citation Analysis]
11 Oikonomou IM, Sinakos E, Antoniadis N, Goulis I, Giouleme O, Anifanti M, Katsanos G, Karakasi KE, Tsoulfas G, Kouidi E. Effects of an active lifestyle on the physical frailty of liver transplant candidates. World J Transplant 2022; 12(11): 365-377 [DOI: 10.5500/wjt.v12.i11.365] [Reference Citation Analysis]
12 Kao J, Reid N, Hubbard RE, Homes R, Hanjani LS, Pearson E, Logan B, King S, Fox S, Gordon EH. Frailty and solid-organ transplant candidates: a scoping review. BMC Geriatr 2022;22:864. [DOI: 10.1186/s12877-022-03485-7] [Reference Citation Analysis]
13 Yoshioka Y, Oshima Y, Hata K, Sato S, Hamada R, Sato T, Kaido T, Munekage F, Ito T, Ikeguchi R, Uemoto S, Hatano E, Matsuda S. Factors associated with early postoperative exercise tolerance after living-donor liver transplantation. Clin Transplant 2022;36:e14800. [PMID: 35993374 DOI: 10.1111/ctr.14800] [Reference Citation Analysis]
14 Nguyen VV, Wang S, Whitlock R, Xu C, Taneja S, Singh S, Abraldes JG, Burak K, Bailey RJ, Grab JD, Lai JC, Tandon P. A chair-stand time of greater than 15 seconds is associated with an increased risk of death and hospitalization in cirrhosis. Canadian Liver Journal 2022. [DOI: 10.3138/canlivj-2022-0021] [Reference Citation Analysis]
15 Panayotova GG, Simonishvili S, Nguyen DT, Graviss EA, Aware N, Manner CJ, Minze LJ, Ayorinde T, Qin Y, Jin L, Moore L, Paterno F, Saharia A, Mobley CM, Amin A, Hobeika MJ, Pyrsopoulos N, Li XC, Guarrera JV, Ghobrial RM, Lunsford KE. Identification and Internal Validation of a Novel Pre-Transplant Biomarker Panel to Predict Mortality Following Liver Transplantation: The Liver Immune Frailty Index.. [DOI: 10.21203/rs.3.rs-2134172/v1] [Reference Citation Analysis]
16 European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu, European Association for the Study of the Liver. EASL Clinical Practice Guidelines on the management of cystic liver diseases. J Hepatol 2022;77:1083-108. [PMID: 35728731 DOI: 10.1016/j.jhep.2022.06.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
17 Guarino M, Cossiga V, Becchetti C, Invernizzi F, Lapenna L, Lavezzo B, Lenci I, Merli M, Pasulo L, Zanetto A, Burra P, Morisco F; Special Interest Group Gender in Hepatology of the Italian Association for the Study of the Liver (AISF). Sarcopenia in chronic advanced liver diseases: A sex-oriented analysis of the literature. Dig Liver Dis 2022;54:997-1006. [PMID: 34789397 DOI: 10.1016/j.dld.2021.10.010] [Reference Citation Analysis]
18 van Dijk AM, Coppens BJP, van Beers MA, Bruins Slot AS, Verstraete CJR, de Bruijne J, Vleggaar FP, van Erpecum KJ. Nutritional status in patients with hepatocellular carcinoma: Potential relevance for clinical outcome. Eur J Intern Med 2022:S0953-6205(22)00250-3. [PMID: 35902333 DOI: 10.1016/j.ejim.2022.07.002] [Reference Citation Analysis]
19 Duarte-rojo A, Brown RA, Bloomer PM, Nunez Duarte M, Grubbs RK, Hernaez R. A Telemedicine Alternative to the 6-Minute Walk Test Using Personal Activity Trackers in Liver Transplant Candidates. Transplantation Direct 2022;8:e1347. [DOI: 10.1097/txd.0000000000001347] [Reference Citation Analysis]
20 Paternostro R, Trauner M. Current treatment of non-alcoholic fatty liver disease. J Intern Med 2022. [PMID: 35796150 DOI: 10.1111/joim.13531] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
21 Hosoda K, Shimizu A, Kubota K, Notake T, Masuo H, Yoshizawa T, Sakai H, Hayashi H, Yasukawa K, Soejima Y. Usefulness of frailty to predict short‐ and long‐term outcomes in patients who have undergone major hepatectomy for perihilar cholangiocarcinoma. Annals of Gastroent Surgery. [DOI: 10.1002/ags3.12596] [Reference Citation Analysis]
22 Fernández-alonso V, Hernández-matías AM, Díaz-serrano MT, Hernández-caballero AB, Pérez-gómez M. Analysis of the impact of liver transplantation as a condition of health. Enfermería Clínica (English Edition) 2022;32:249-256. [DOI: 10.1016/j.enfcle.2022.03.005] [Reference Citation Analysis]
23 Song Y, Wang Y, Zang C, Yang X, Li Z, Wu L, Li K. Prognostic Nomograms for Hospital Survival and Transplant-Free Survival of Patients with Hepatorenal Syndrome: A Retrospective Cohort Study. Diagnostics 2022;12:1417. [DOI: 10.3390/diagnostics12061417] [Reference Citation Analysis]
24 Carey EJ. Survival of the less-fit. Hepatology 2022;75:1368-9. [PMID: 34953148 DOI: 10.1002/hep.32300] [Reference Citation Analysis]
25 Ge J, Kim WR, Lai JC, Kwong AJ. "Beyond MELD" - Emerging strategies and technologies for improving mortality prediction, organ allocation and outcomes in liver transplantation. J Hepatol 2022;76:1318-29. [PMID: 35589253 DOI: 10.1016/j.jhep.2022.03.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
26 Lai JC, Shui AM, Duarte-Rojo A, Ganger DR, Rahimi RS, Huang CY, Yao F, Kappus M, Boyarsky B, McAdams-Demarco M, Volk ML, Dunn MA, Ladner DP, Segev DL, Verna EC, Feng S; from the Multi-Center Functional Assessment in Liver Transplantation (FrAILT) Study. Frailty, mortality, and health care utilization after liver transplantation: From the Multicenter Functional Assessment in Liver Transplantation (FrAILT) Study. Hepatology 2022;75:1471-9. [PMID: 34862808 DOI: 10.1002/hep.32268] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
27 Orange ST, Hallsworth K, Brown MC, Reeves HL. The feasibility and acceptability of a home-based, virtual exercise intervention for older patients with hepatocellular carcinoma: protocol for a non-randomised feasibility study (TELEX-Liver Cancer). Pilot Feasibility Stud 2022;8:113. [PMID: 35624520 DOI: 10.1186/s40814-022-01069-1] [Reference Citation Analysis]
28 Rabei R, Vakil P, King B, Lokken RP, Heller M, Fidelman N, Kohi M. Frailty as a Predictor of Complications and Transplant-Free Survival after Transarterial Chemoembolization of Hepatocellular Carcinoma. Journal of Clinical Interventional Radiology ISVIR. [DOI: 10.1055/s-0042-1745775] [Reference Citation Analysis]
29 Tejedor M, Selzner N, Berenguer M. Are MELD and MELDNa Still Reliable Tools to Predict Mortality on the Liver Transplant Waiting List? Transplantation 2022. [PMID: 35594480 DOI: 10.1097/TP.0000000000004163] [Reference Citation Analysis]
30 Naimimohasses S, O'Gorman P, McCormick E, Ferguson D, Monaghan A, McGrath M, Robinson MW, Gormley J, Norris S. Prevalence of frailty in patients with non-cirrhotic non-alcoholic fatty liver disease. BMJ Open Gastroenterol 2022;9. [PMID: 35523460 DOI: 10.1136/bmjgast-2021-000861] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
31 Rich NE, Phen S, Desai N, Mittal S, Yopp AC, Yang JD, Marrero JA, Iyengar P, Infante RE, Singal AG. Cachexia is Prevalent in Patients With Hepatocellular Carcinoma and Associated With Worse Prognosis. Clin Gastroenterol Hepatol 2022;20:e1157-69. [PMID: 34555519 DOI: 10.1016/j.cgh.2021.09.022] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
32 Fernández-alonso V, Hernández-matías AM, Díaz-serrano MT, Hernández-caballero AB, Pérez-gómez M. Análisis del impacto del trasplante hepático como condicionante de salud. Enfermería Clínica 2022. [DOI: 10.1016/j.enfcli.2022.03.006] [Reference Citation Analysis]
33 Shah ND, Barritt AS. Nutrition as Therapy in Liver Disease. Clinical Therapeutics 2022. [DOI: 10.1016/j.clinthera.2022.04.012] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
34 Kaps L, Lukac L, Michel M, Kremer WM, Hilscher M, Gairing SJ, Galle PR, Schattenberg JM, Wörns M, Nagel M, Labenz C. Liver Frailty Index for Prediction of Short-Term Rehospitalization in Patients with Liver Cirrhosis. Diagnostics 2022;12:1069. [DOI: 10.3390/diagnostics12051069] [Reference Citation Analysis]
35 Koons B, Anderson MR, Smith PJ, Greenland JR, Singer JP. The Intersection of Aging and Lung Transplantation: its Impact on Transplant Evaluation, Outcomes, and Clinical Care. Curr Transpl Rep. [DOI: 10.1007/s40472-022-00365-2] [Reference Citation Analysis]
36 Li C, Zhao C, Yu Z, Yang W, Sun M, Li Y, Guo G, Hui Y, Wang X, Fan X, Wang B, Zhang J, Sun C. Low free triiodothyronine levels are associated with frail phenotype in hospitalized inpatients with cirrhosis. Postgrad Med 2022. [PMID: 35382681 DOI: 10.1080/00325481.2022.2063487] [Reference Citation Analysis]
37 Corradi M, Mazzarelli C, Cesari M, Viganò R, Belli LS. Implementation of the frailty assessment to improve liver transplant outcomes. Aging Clin Exp Res 2022. [PMID: 35380349 DOI: 10.1007/s40520-022-02111-1] [Reference Citation Analysis]
38 Bowers SP, Clare K, Hagerty L, Mccoll K, Smith E, Brown-kerr A, Ahmed A, Finlay F, Dillon JF, Barclay S. Predicting 1-year mortality among patients with decompensated cirrhosis: results of a multicentre evaluation of the Bristol Prognostic Score. BMJ Open Gastroenterol 2022;9:e000822. [DOI: 10.1136/bmjgast-2021-000822] [Reference Citation Analysis]
39 Wang S, Whitlock R, Xu C, Taneja S, Singh S, Abraldes JG, Burak KW, Bailey RJ, Lai JC, Tandon P. Frailty is associated with increased risk of cirrhosis disease progression and death. Hepatology 2022;75:600-9. [PMID: 34528267 DOI: 10.1002/hep.32157] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 11.0] [Reference Citation Analysis]
40 Parente A, Ronca V. Assessment of advanced age candidates for liver transplantation warrants more caution. World J Transplant 2022; 12(2): 24-26 [DOI: 10.5500/wjt.v12.i2.24] [Reference Citation Analysis]
41 Deng LX, Kent DS, O'Riordan DL, Pantilat SZ, Lai JC, Bischoff KE. Symptom Burden Is Associated with Increased Emergency Department Utilization among Patients with Cirrhosis. J Palliat Med 2022;25:213-8. [PMID: 34348042 DOI: 10.1089/jpm.2021.0219] [Reference Citation Analysis]
42 Spoletini G, Ferri F, Mauro A, Mennini G, Bianco G, Cardinale V, Agnes S, Rossi M, Avolio AW, Lai Q. CONUT Score Predicts Early Morbidity After Liver Transplantation: A Collaborative Study. Front Nutr 2021;8:793885. [PMID: 35071299 DOI: 10.3389/fnut.2021.793885] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
43 Kochar B, Ufere NN, Ritchie CS, Lai JC. The 5Ms of Geriatrics in Gastroenterology: The Path to Creating Age-Friendly Care for Older Adults With Inflammatory Bowel Diseases and Cirrhosis. Clin Transl Gastroenterol 2022. [PMID: 35080513 DOI: 10.14309/ctg.0000000000000445] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
44 Gnanadeepam S, Janeela AM, Zachariah U, Eapen CE, Goel A. Sarcopenia is Closely Associated With Frailty in Decompensated Cirrhosis. J Clin Exp Hepatol 2022;12:237-8. [PMID: 35068808 DOI: 10.1016/j.jceh.2021.09.021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
45 Wang S, Tandon P. The Impact of Sarcopenia, Frailty, and Malnutrition on Further Decompensation. Portal Hypertension VII 2022. [DOI: 10.1007/978-3-031-08552-9_50] [Reference Citation Analysis]
46 Singh S, Taneja S, Tandon P, De A, Verma N, Premkumar M, Duseja A, Dhiman RK, Singh V. High Prevalence of Hormonal Changes and Hepatic Osteodystrophy in Frail Patients with Cirrhosis-An Observational Study. J Clin Exp Hepatol 2022;12:800-7. [PMID: 35677501 DOI: 10.1016/j.jceh.2021.11.012] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
47 Singh S, Taneja S, Tandon P, Bansal A, Gorsi U, Roy A, De A, Verma N, Premkumar M, Duseja A, Dhiman RK, Singh V. A Comparison of Different Frailty Scores and Impact of Frailty on Outcome in Patients With Cirrhosis. J Clin Exp Hepatol 2022;12:398-408. [PMID: 35535083 DOI: 10.1016/j.jceh.2021.07.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
48 Siddiqui O, Olson S, Thuluvath A, Ladner D. Frailty and Sarcopenia in Cirrhosis. In Clinical Practice 2022. [DOI: 10.1007/978-3-031-10012-3_6] [Reference Citation Analysis]
49 Malinovskaya YO, Kokina KY, Moysyuk YG, Sumtsova OV. The impact of late liver allograft dysfunction on physical activity of liver transplant recipients. Transplantologiâ (Mosk ) 2021;13:356-366. [DOI: 10.23873/2074-0506-2021-13-4-356-366] [Reference Citation Analysis]
50 Kim WR, Mannalithara A, Heimbach JK, Kamath PS, Asrani SK, Biggins SW, Wood NL, Gentry SE, Kwong AJ. MELD 3.0: The Model for End-Stage Liver Disease Updated for the Modern Era. Gastroenterology 2021;161:1887-1895.e4. [PMID: 34481845 DOI: 10.1053/j.gastro.2021.08.050] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 20.5] [Reference Citation Analysis]
51 Serper M, Tao SY, Kent DS, Garren P, Burdzy AE, Lai JC, Gougol A, Bloomer PM, Reddy KR, Dunn MA, Duarte-Rojo A. Inpatient Frailty Assessment Is Feasible and Predicts Nonhome Discharge and Mortality in Decompensated Cirrhosis. Liver Transpl 2021;27:1711-22. [PMID: 34018303 DOI: 10.1002/lt.26100] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
52 Ferreira AP, Machado MV. Impact of pretransplant frailty and sarcopenia on the post-transplant prognosis of patients with liver cirrhosis: a systematic review. Eur J Gastroenterol Hepatol 2021;33:e883-97. [PMID: 35048655 DOI: 10.1097/MEG.0000000000002291] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
53 Hui Y, Xu L, Wang X, Feng H, Yu Z, Li C, Mao L, Fan X, Wang B, Chen X, Sun C. Association between sleep disturbance and multidimensional frailty assessed by Frailty Index in hospitalized cirrhosis. Eur J Gastroenterol Hepatol 2021;33:e727-33. [PMID: 34101682 DOI: 10.1097/MEG.0000000000002231] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
54 Deng LX, Bischoff KE, Kent DS, O'Riordan DL, Pantilat SZ, Lai JC. Frailty is strongly associated with self-reported symptom burden among patients with cirrhosis. Eur J Gastroenterol Hepatol 2021;33:e395-400. [PMID: 33731588 DOI: 10.1097/MEG.0000000000002113] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
55 Zhou K, Dodge JL, Xu E, Emamaullee J, Kahn JA. Excess liver transplant waitlist mortality for patients with primary biliary cholangitis under MELD-Na allocation. Clin Transplant 2021;:e14527. [PMID: 34731515 DOI: 10.1111/ctr.14527] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
56 Mendoza YP, Becchetti C, Watt KD, Berzigotti A. Risks and Rewards of Bariatric Surgery in Advanced Chronic Liver Diseases. Semin Liver Dis 2021;41:448-60. [PMID: 34243194 DOI: 10.1055/s-0041-1731705] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
57 Hernández-Conde M, Llop E, Gómez-Pimpollo L, Fernández Carrillo C, Rodríguez L, Van Den Brule E, Perelló C, López-Gómez M, Abad J, Martínez-Porras JL, Fernández-Puga N, Ferre C, Trapero M, Fraga E, Calleja JL. Adding Branched-Chain Amino Acids to an Enhanced Standard-of-Care Treatment Improves Muscle Mass of Cirrhotic Patients With Sarcopenia: A Placebo-Controlled Trial. Am J Gastroenterol 2021;116:2241-9. [PMID: 34074812 DOI: 10.14309/ajg.0000000000001301] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 7.5] [Reference Citation Analysis]
58 Cullaro G, Verna EC, Duarte-Rojo A, Kappus MR, Ganger DR, Rahimi RS, Boyarsky B, Segev DL, McAdams-DeMarco M, Ladner DP, Volk ML, Hsu CY, Lai JC. Frailty and the Risk of Acute Kidney Injury Among Patients With Cirrhosis. Hepatol Commun 2021. [PMID: 34676697 DOI: 10.1002/hep4.1840] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
59 Ruiz-Margáin A, Román-Calleja BM, Moreno-Guillén P, González-Regueiro JA, Kúsulas-Delint D, Campos-Murguía A, Flores-García NC, Macías-Rodríguez RU. Nutritional therapy for hepatocellular carcinoma. World J Gastrointest Oncol 2021; 13(10): 1440-1452 [PMID: 34721776 DOI: 10.4251/wjgo.v13.i10.1440] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
60 Ito T, Guorgui J, Markovic D, Coy H, Younan SM, DiNorcia J 3rd, Agopian VG, Farmer DG, Raman SS, Busuttil RW, Kaldas FM. Sarcopenia in high acuity liver transplantation: Does it predict outcomes? Clin Transplant 2021;:e14503. [PMID: 34634157 DOI: 10.1111/ctr.14503] [Reference Citation Analysis]
61 Siramolpiwat S, Kiattikunrat K, Soontararatpong R, Pornthisarn B, Vilaichone RK, Chonprasertsuk S, Bhanthumkomol P, Nunanun P, Issariyakulkarn N. Frailty as tested by the Liver Frailty Index is associated with decompensation and unplanned hospitalization in patients with compensated cirrhosis. Scand J Gastroenterol 2021;56:1210-9. [PMID: 34338110 DOI: 10.1080/00365521.2021.1957497] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
62 Xu CQ, Mohamad Y, Kappus MR, Boyarsky B, Ganger DR, Volk ML, Rahimi RS, Duarte-Rojo A, McAdams-DeMarco M, Segev DL, Ladner DP, Verna EC, Grab J, Tincopa M, Dunn MA, Lai JC. The relationship between frailty and cirrhosis etiology: From the Functional Assessment in Liver Transplantation (FrAILT) Study. Liver Int 2021;41:2467-73. [PMID: 34219362 DOI: 10.1111/liv.15006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
63 Bunchorntavakul C, Reddy KR. Letter: patients who have both sarcopenia and frailty have similar prognosis to those with either condition separately-authors' reply. Aliment Pharmacol Ther 2021;54:983-4. [PMID: 34506657 DOI: 10.1111/apt.16581] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
64 Louissaint J, Murphy SL, Sonnenday CJ, Lok AS, Tapper EB. Applying Administrative Data-Based Coding Algorithms for Frailty in Patients With Cirrhosis. Liver Transpl 2021;27:1401-11. [PMID: 33871175 DOI: 10.1002/lt.26078] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
65 Alexopoulos T, Vasilieva L, Kontogianni MD, Mani I, Alexopoulou A. Letter: patients who have both sarcopenia and frailty have similar prognosis to those with either condition separately. Aliment Pharmacol Ther 2021;54:981-2. [PMID: 34506659 DOI: 10.1111/apt.16564] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
66 Lin FP, Visina JM, Bloomer PM, Dunn MA, Josbeno DA, Zhang X, Clemente-Sanchez A, Tevar AD, Hughes CB, Jakicic JM, Duarte-Rojo A. Prehabilitation-Driven Changes in Frailty Metrics Predict Mortality in Patients With Advanced Liver Disease. Am J Gastroenterol 2021;116:2105-17. [PMID: 34313620 DOI: 10.14309/ajg.0000000000001376] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 6.5] [Reference Citation Analysis]
67 Kochar B, Orkaby AR, Ananthakrishnan AN, Ritchie CS. Frailty in inflammatory bowel diseases: an emerging concept. Therap Adv Gastroenterol 2021;14:17562848211025474. [PMID: 34594400 DOI: 10.1177/17562848211025474] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
68 Hui Y, Wang X, Yu Z, Feng H, Li C, Mao L, Fan X, Lin L, Cui B, Chen X, Sun L, Wang B, Sun C. Relationship Between Sleep-Wake Disturbance and Risk of Malnutrition in Hospitalized Patients With Cirrhosis. Front Nutr 2021;8:719176. [PMID: 34532336 DOI: 10.3389/fnut.2021.719176] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
69 Kremer WM, Nagel M, Reuter M, Hilscher M, Michel M, Kaps L, Labenz J, Galle PR, Sprinzl MF, Wörns MA, Labenz C. Validation of the Clinical Frailty Scale for the Prediction of Mortality in Patients With Liver Cirrhosis. Clin Transl Gastroenterol 2020;11:e00211. [PMID: 32764204 DOI: 10.14309/ctg.0000000000000211] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
70 Tapper EB, Nikirk S, Parikh ND, Zhao L. Falls are common, morbid, and predictable in patients with cirrhosis. J Hepatol 2021;75:582-8. [PMID: 33887359 DOI: 10.1016/j.jhep.2021.04.012] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
71 Lai JC, Tandon P, Bernal W, Tapper EB, Ekong U, Dasarathy S, Carey EJ. Malnutrition, Frailty, and Sarcopenia in Patients With Cirrhosis: 2021 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology 2021;74:1611-44. [PMID: 34233031 DOI: 10.1002/hep.32049] [Cited by in Crossref: 79] [Cited by in F6Publishing: 61] [Article Influence: 39.5] [Reference Citation Analysis]
72 Berry K, Duarte-Rojo A, Grab JD, Dunn MA, Boyarsky BJ, Verna EC, Kappus MR, Volk ML, McAdams-DeMarco M, Segev DL, Ganger DR, Ladner DP, Shui A, Tincopa MA, Rahimi RS, Lai JC; from the Multi-Center Functional Assessment in Liver Transplantation (FrAILT) Study. Cognitive Impairment and Physical Frailty in Patients With Cirrhosis. Hepatol Commun 2021. [PMID: 34558844 DOI: 10.1002/hep4.1796] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
73 Javaid N, Iqbal AZ, Hameeda M. NUTRITIONAL MANAGEMENT OF LIVER CIRRHOSIS AND ITS COMPLICATIONS IN HOSPITALIZED PATIENTS. Arq Gastroenterol 2021;58:246-52. [PMID: 34287534 DOI: 10.1590/S0004-2803.202100000-43] [Reference Citation Analysis]
74 Boursier J, Anty R, Carette C, Cariou B, Castera L, Caussy C, Fontaine H, Garioud A, Gourdy P, Guerci B, Guillaume M, Michot N, Minello A, Ouizeman DJ, Serfaty L, Bonnet F, Vergès B, Petit JM; AFEF and SFD. Management of diabetes mellitus in patients with cirrhosis: An overview and joint statement. Diabetes Metab 2021;47:101272. [PMID: 34363981 DOI: 10.1016/j.diabet.2021.101272] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
75 Ayorinde T, Panayotova G, Sharma A, Lunsford KE. Clinical and biomarker assessment of frailty in liver transplantation. Curr Opin Organ Transplant 2021. [PMID: 34343156 DOI: 10.1097/MOT.0000000000000911] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
76 Ivanics T, Abreu P, De Martin E, Sapisochin G. Changing Trends in Liver Transplantation: Challenges and Solutions. Transplantation 2021;105:743-56. [PMID: 32910093 DOI: 10.1097/TP.0000000000003454] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 7.5] [Reference Citation Analysis]
77 Kriss M, Biggins SW. Evaluation and selection of the liver transplant candidate: updates on a dynamic and evolving process. Curr Opin Organ Transplant 2021;26:52-61. [PMID: 33278150 DOI: 10.1097/MOT.0000000000000829] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
78 Rodríguez-Perálvarez M, Gómez-Bravo MÁ, Sánchez-Antolín G, De la Rosa G, Bilbao I, Colmenero J; Spanish Society of Liver Transplantation (SETH) Consensus Panel. Expanding Indications of Liver Transplantation in Spain: Consensus Statement and Recommendations by the Spanish Society of Liver Transplantation. Transplantation 2021;105:602-7. [PMID: 32345868 DOI: 10.1097/TP.0000000000003281] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 6.5] [Reference Citation Analysis]
79 Chakravarthy MV, Neutel J, Confer S, Zhao P, Tatsuta N, Rebello S, Comb WC, Hamill M, Tramontin T, Carroll S, Afeyan R, Sanyal AJ. Safety, Tolerability, and Physiological Effects of AXA1665, a Novel Composition of Amino Acids, in Subjects With Child-Pugh A and B Cirrhosis. Clin Transl Gastroenterol 2020;11:e00222. [PMID: 32955200 DOI: 10.14309/ctg.0000000000000222] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
80 Lattanzi B, Bruni A, Di Cola S, Molfino A, De Santis A, Muscaritoli M, Merli M. The Effects of 12-Week Beta-Hydroxy-Beta-Methylbutyrate Supplementation in Patients with Liver Cirrhosis: Results from a Randomized Controlled Single-Blind Pilot Study. Nutrients 2021;13:2296. [PMID: 34371806 DOI: 10.3390/nu13072296] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
81 Burra P, Samuel D, Sundaram V, Duvoux C, Petrowsky H, Terrault N, Jalan R. Limitations of current liver donor allocation systems and the impact of newer indications for liver transplantation. J Hepatol 2021;75 Suppl 1:S178-90. [PMID: 34039488 DOI: 10.1016/j.jhep.2021.01.007] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 7.5] [Reference Citation Analysis]
82 Bhanji RA, Watt KD. Physiologic Reserve Assessment and Application in Clinical and Research Settings in Liver Transplantation. Liver Transpl 2021;27:1041-53. [PMID: 33713382 DOI: 10.1002/lt.26052] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
83 Nishikawa H, Yoh K, Enomoto H, Iwata Y, Sakai Y, Kishino K, Shimono Y, Ikeda N, Takashima T, Aizawa N, Takata R, Hasegawa K, Koriyama T, Yuri Y, Nishimura T, Nishiguchi S, Iijima H. Sarcopenia and Frailty in Chronic Liver Damage: Common and Different Points. In Vivo 2020;34:2549-59. [PMID: 32871784 DOI: 10.21873/invivo.12072] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
84 Skladany L, Molcan P, Vnencakova J, Vrbova P, Kukla M, Laffers L, Koller T. Frailty in Nonalcoholic Fatty Liver Cirrhosis: A Comparison with Alcoholic Cirrhosis, Risk Patterns, and Impact on Prognosis. Can J Gastroenterol Hepatol 2021;2021:5576531. [PMID: 34095016 DOI: 10.1155/2021/5576531] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
85 Renau LP, López JH, Cebrià I Iranzo MÀ, Serrano NC, Di Maira T, Berenguer M. Frailty and Sarcopenia in Acute-on-Chronic Liver Failure. Hepatol Commun 2021;5:1333-47. [PMID: 34430779 DOI: 10.1002/hep4.1722] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
86 Zelber-Sagi S, Ivancovsky-Wajcman D, Rabinowich L, Bentov I, Deutsch L. Nutritional Evaluation and Treatment of the Cirrhotic Patient. Clin Liver Dis 2021;25:373-92. [PMID: 33838856 DOI: 10.1016/j.cld.2021.01.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
87 Duong N, Sadowski B, Rangnekar AS. The Impact of Frailty, Sarcopenia, and Malnutrition on Liver Transplant Outcomes. Clin Liver Dis (Hoboken) 2021;17:271-6. [PMID: 33968388 DOI: 10.1002/cld.1043] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
88 Dunn MA, Kappus MR, Bloomer PM, Duarte-Rojo A, Josbeno DA, Jakicic JM. Wearables, Physical Activity, and Exercise Testing in Liver Disease. Semin Liver Dis 2021;41:128-35. [PMID: 33788206 DOI: 10.1055/s-0040-1716564] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
89 Nishikawa H, Fukunishi S, Asai A, Nishiguchi S, Higuchi K. Sarcopenia and Frailty in Liver Cirrhosis. Life (Basel) 2021;11:399. [PMID: 33925660 DOI: 10.3390/life11050399] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
90 Winston J, Guzman Rojas P, Stocker A, Mathur P, Lorenz D, Daniels M, Abell T. Development of a Motility Frailty Index in Patients with Gastroparesis. GastrointestDisord 2021;3:78-83. [DOI: 10.3390/gidisord3020008] [Reference Citation Analysis]
91 Burke NT, Maurice JB, Nasralla D, Potts J, Westbrook R. Recent advances in liver transplantation. Frontline Gastroenterol 2022;13:57-63. [PMID: 34970429 DOI: 10.1136/flgastro-2020-101425] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
92 Son SW, Song DS, Chang UI, Yang JM. Definition of Sarcopenia in Chronic Liver Disease. Life (Basel) 2021;11:349. [PMID: 33923561 DOI: 10.3390/life11040349] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
93 Kok B, McNeely M, Watt M, Tandon P. Exercise Only Works If You Do It! The Holy Grail of Adherence. Am J Gastroenterol 2021;116:673-4. [PMID: 33982935 DOI: 10.14309/ajg.0000000000001198] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
94 Duarte-Rojo A, Bloomer PM, Rogers RJ, Hassan MA, Dunn MA, Tevar AD, Vivis SL, Bataller R, Hughes CB, Ferrando AA, Jakicic JM, Kim WR. Introducing EL-FIT (Exercise and Liver FITness): A Smartphone App to Prehabilitate and Monitor Liver Transplant Candidates. Liver Transpl 2021;27:502-12. [PMID: 33232547 DOI: 10.1002/lt.25950] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 10.0] [Reference Citation Analysis]
95 Lai JC, Dodge JL, Kappus MR, Wong R, Mohamad Y, Segev DL, McAdams-DeMarco M. A Multicenter Pilot Randomized Clinical Trial of a Home-Based Exercise Program for Patients With Cirrhosis: The Strength Training Intervention (STRIVE). Am J Gastroenterol 2021;116:717-22. [PMID: 33982941 DOI: 10.14309/ajg.0000000000001113] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
96 Acharya C, White MB, Fagan A, Sterling RK, Stravitz RT, Puri P, Fuchs M, Luketic V, Sanyal AJ, Wade JB, Gilles H, Heuman DM, Tinsley F, Matherly S, Lee H, Siddiqui MS, Thacker LR, Bajaj JS. Liver Transplant Is Associated with Sustained Improvement in Tandem Gait and Risk of Falls. Dig Dis Sci 2021;66:1360-6. [PMID: 32323075 DOI: 10.1007/s10620-020-06261-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
97 Tandon P, Walling A, Patton H, Taddei T. AGA Clinical Practice Update on Palliative Care Management in Cirrhosis: Expert Review. Clin Gastroenterol Hepatol 2021;19:646-656.e3. [PMID: 33221550 DOI: 10.1016/j.cgh.2020.11.027] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 8.0] [Reference Citation Analysis]
98 Sidhu SS, Saggar K, Goyal O, Varshney T, Kishore H, Bansal N, Sidhu SS. Muscle strength and physical performance, rather than muscle mass, correlate with mortality in end-stage liver disease. Eur J Gastroenterol Hepatol 2021;33:555-64. [PMID: 32433422 DOI: 10.1097/MEG.0000000000001761] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
99 Spiers GF, Kunonga TP, Hall A, Beyer F, Boulton E, Parker S, Bower P, Craig D, Todd C, Hanratty B. Measuring frailty in younger populations: a rapid review of evidence. BMJ Open 2021;11:e047051. [PMID: 33753447 DOI: 10.1136/bmjopen-2020-047051] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
100 Waterman BL, Ramsey SU, Whitsett MP, Patel AA, Radcliff JA, Kotler DL, Winters AC, Woodrell CD, Ufere NN, Serper M, Walling AM, Jones CA, Kelly SG. Top Ten Tips Palliative Care Clinicians Should Know About End-Stage Liver Disease. J Palliat Med 2021;24:924-31. [PMID: 33733875 DOI: 10.1089/jpm.2021.0097] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
101 Kapacee ZA, Mcnamara MG, de Liguori Carino N, Lamarca A, Valle JW, Hubner RA. Systemic therapies in advanced hepatocellular carcinoma: How do older patients fare? European Journal of Surgical Oncology 2021;47:583-90. [DOI: 10.1016/j.ejso.2020.03.210] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
102 Kardashian A, Ge J, McCulloch CE, Kappus MR, Dunn MA, Duarte-Rojo A, Volk ML, Rahimi RS, Verna EC, Ganger DR, Ladner D, Dodge JL, Boyarsky B, McAdams-DeMarco M, Segev DL, Lai JC. Identifying an Optimal Liver Frailty Index Cutoff to Predict Waitlist Mortality in Liver Transplant Candidates. Hepatology 2021;73:1132-9. [PMID: 32491208 DOI: 10.1002/hep.31406] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 10.5] [Reference Citation Analysis]
103 Williams FR, Milliken D, Lai JC, Armstrong MJ. Assessment of the Frail Patient With End-Stage Liver Disease: A Practical Overview of Sarcopenia, Physical Function, and Disability. Hepatol Commun 2021;5:923-37. [PMID: 34141980 DOI: 10.1002/hep4.1688] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
104 Varughese RA, Theou O, Li Y, Huang X, Chowdhury N, Famure O, Selzner N, MacIver J, Mathur S, Kim SJ, Rockwood K, Singer LG. Cumulative Deficits Frailty Index Predicts Outcomes for Solid Organ Transplant Candidates. Transplant Direct 2021;7:e677. [PMID: 34113716 DOI: 10.1097/TXD.0000000000001094] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
105 Orman ES, Johnson AW, Ghabril M, Sachs GA. Hospice care for end stage liver disease in the United States. Expert Rev Gastroenterol Hepatol 2021;15:797-809. [PMID: 33599185 DOI: 10.1080/17474124.2021.1892487] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
106 Traub J, Reiss L, Aliwa B, Stadlbauer V. Malnutrition in Patients with Liver Cirrhosis. Nutrients 2021;13:540. [PMID: 33562292 DOI: 10.3390/nu13020540] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
107 Abdelbasset WK, Nambi G, Elsayed SH, Moawd SA, Ibrahim AA, Verma A, Tantawy SA, Kamel DM, Saleh AK, Aldhafian OR, Nwihadh NB. Prevalence and Nonpharmacological Interventions for Sarcopenia among Cirrhotic Patients. Dis Markers 2021;2021:8866093. [PMID: 33628339 DOI: 10.1155/2021/8866093] [Reference Citation Analysis]
108 Saiman Y, Serper M. Frailty and Sarcopenia in Patients Pre- and Post-Liver Transplant. Clin Liver Dis 2021;25:35-51. [PMID: 33978582 DOI: 10.1016/j.cld.2020.08.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
109 Xu CQ, Yao F, Mohamad Y, Wong R, Kent D, Seetharaman S, Srisengfa Y, Lai JC. Evaluating the Associations Between the Liver Frailty Index and Karnofsky Performance Status With Waitlist Mortality. Transplant Direct 2021;7:e651. [PMID: 33437866 DOI: 10.1097/TXD.0000000000001097] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
110 Tsuchihashi J, Koya S, Hirota K, Koga N, Narao H, Tomita M, Kawaguchi T, Hashida R, Nakano D, Tsutsumi T, Yoshio S, Matsuse H, Sanada T, Notsumata K, Torimura T. Effects of In-Hospital Exercise on Frailty in Patients with Hepatocellular Carcinoma. Cancers (Basel) 2021;13:E194. [PMID: 33430438 DOI: 10.3390/cancers13020194] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
111 Loughnan A, Nair S, James S. The Role of Cardiopulmonary Exercise Testing (CPET) in the Preoperative Assessment of Patients for Hepatico-Pancreatic-Biliary (HPB) Surgery and Liver Transplantation (LT). Anesthesia for Hepatico-Pancreatic-Biliary Surgery and Transplantation 2021. [DOI: 10.1007/978-3-030-51331-3_7] [Reference Citation Analysis]
112 Wadhwani SI, Bucuvalas JC. Health System Requirements for Pediatric Liver Transplantation. Pediatric Liver Transplantation 2021. [DOI: 10.1016/b978-0-323-63671-1.00003-3] [Reference Citation Analysis]
113 Puri P, Dhiman RK, Taneja S, Tandon P, Merli M, Anand AC, Arora A, Acharya SK, Benjamin J, Chawla YK, Dadhich S, Duseja A, Eapan CE, Goel A, Kalra N, Kapoor D, Kumar A, Madan K, Nagral A, Pandey G, Rao PN, Saigal S, Saraf N, Saraswat VA, Saraya A, Sarin SK, Sharma P, Shalimar, Shukla A, Sidhu SS, Singh N, Singh SP, Srivastava A, Wadhawan M. Nutrition in Chronic Liver Disease: Consensus Statement of the Indian National Association for Study of the Liver. J Clin Exp Hepatol 2021;11:97-143. [PMID: 33679050 DOI: 10.1016/j.jceh.2020.09.003] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
114 Wong RJ, Mohamad Y, Srisengfa YT, Kent DS, Seetharaman S, Shah RJ, Lai JC. Psychological contributors to the frail phenotype: The association between resilience and frailty in patients with cirrhosis. Am J Transplant 2021;21:241-6. [PMID: 32524691 DOI: 10.1111/ajt.16131] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
115 Shamseddeen H, Pike F, Ghabril M, Patidar KR, Desai AP, Nephew L, Anderson M, Kubal C, Chalasani N, Orman ES. Karnofsky performance status predicts outcomes in candidates for simultaneous liver-kidney transplant. Clin Transplant 2021;35:e14190. [PMID: 33320383 DOI: 10.1111/ctr.14190] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
116 Zahed M, Ranjbar MA, Azad A. Oral Health-Related Quality of Life in Chronic Liver Failure Patients Measured by OHIP-14 and GOHAI. Biomed Res Int 2020;2020:8835824. [PMID: 33426077 DOI: 10.1155/2020/8835824] [Reference Citation Analysis]
117 Johnston HE, de Crom T, Hargrave C, Adhyaru P, Woodward AJ, Pang S, Ali A, Coombes JS, Keating SE, McLean K, Mayr HL, Macdonald GA, Hickman IJ. The inter- and intrarater reliability and feasibility of dietetic assessment of sarcopenia and frailty in potential liver transplant recipients: A mixed-methods study. Clin Transplant 2021;35:e14185. [PMID: 33306855 DOI: 10.1111/ctr.14185] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
118 Saeki C, Kanai T, Nakano M, Oikawa T, Torisu Y, Saruta M, Tsubota A. Low Serum 25-Hydroxyvitamin D Levels Are Related to Frailty and Sarcopenia in Patients with Chronic Liver Disease. Nutrients 2020;12:E3810. [PMID: 33322706 DOI: 10.3390/nu12123810] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
119 Murphy SL, Richardson JK, Blackwood J, Martinez B, Tapper EB. Neurocognitive and Muscular Capacities Are Associated with Frailty in Adults with Cirrhosis. Dig Dis Sci 2020;65:3734-43. [PMID: 31982996 DOI: 10.1007/s10620-020-06099-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
120 Merli M. Nutrition in cirrhosis: Dos and Don'ts. J Hepatol 2020;73:1563-5. [PMID: 32891430 DOI: 10.1016/j.jhep.2020.07.019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
121 Bittermann T, Dwinnells K, Chadha S, Wolf MS, Olthoff KM, Serper M. Low Health Literacy Is Associated With Frailty and Reduced Likelihood of Liver Transplant Listing: A Prospective Cohort Study. Liver Transpl 2020;26:1409-21. [PMID: 32567232 DOI: 10.1002/lt.25830] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 5.7] [Reference Citation Analysis]
122 Moon AM, Singal AG, Tapper EB. Contemporary Epidemiology of Chronic Liver Disease and Cirrhosis. Clin Gastroenterol Hepatol 2020;18:2650-66. [PMID: 31401364 DOI: 10.1016/j.cgh.2019.07.060] [Cited by in Crossref: 302] [Cited by in F6Publishing: 317] [Article Influence: 100.7] [Reference Citation Analysis]
123 Thompson C, Taleban S. Incorporating Frailty in the Treatment Program of Elderly Patients with Gastrointestinal Disease. Curr Treat Options Gastro 2020;18:635-56. [DOI: 10.1007/s11938-020-00310-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
124 Mikolasevic I, Pavic T, Kanizaj TF, Bender DV, Domislovic V, Krznaric Z. Nonalcoholic Fatty Liver Disease and Sarcopenia: Where Do We Stand? Can J Gastroenterol Hepatol 2020;2020:8859719. [PMID: 33204675 DOI: 10.1155/2020/8859719] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
125 Lin YJ, Chen RJ, Tang JH, Yu CS, Wu JL, Chen LC, Chang SS. Machine-Learning Monitoring System for Predicting Mortality Among Patients With Noncancer End-Stage Liver Disease: Retrospective Study. JMIR Med Inform 2020;8:e24305. [PMID: 33124991 DOI: 10.2196/24305] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
126 Deng Y, Lin L, Hou L, Fan X, Zhao T, Mao L, Wang X, Wang B, Ma Y, Sun C. A self-reported Frailty Index predicts long-term mortality in hospitalized patients with cirrhosis. Ann Transl Med 2020;8:1217. [PMID: 33178749 DOI: 10.21037/atm-20-943] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
127 Burton JR Jr, Terrault NA, Goldberg DS, Bloom RD, Gilroy R, Heimbach JK, Brown RS Jr, Everson GT, Rubin E, Wiesner R, Pomfret EA. Liver and Kidney Recipient Selection of Hepatitis C Virus Viremic Donors: Meeting Consensus Report From the 2019 Controversies in Transplantation. Transplantation 2020;104:476-81. [PMID: 31634329 DOI: 10.1097/TP.0000000000003014] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
128 Kukla M, Skladany L, Menżyk T, Derra A, Stygar D, Skonieczna M, Hudy D, Nabrdalik K, Gumprecht J, Marlicz W, Koulaouzidis A, Koller T. Irisin in Liver Cirrhosis. J Clin Med 2020;9:E3158. [PMID: 33003490 DOI: 10.3390/jcm9103158] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
129 Mazumder NR, Atiemo K, Kappus M, Cullaro G, Harinstein ME, Ladner D, Verna E, Lai J, Levitsky J. A Comprehensive Review of Outcome Predictors in Low MELD Patients. Transplantation 2020;104:242-50. [PMID: 31517785 DOI: 10.1097/TP.0000000000002956] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
130 Fozouni L, Wang CW, Lai JC. Sex Differences in the Association Between Frailty and Sarcopenia in Patients With Cirrhosis. Clin Transl Gastroenterol 2019;10:e00102. [PMID: 31789932 DOI: 10.14309/ctg.0000000000000102] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
131 Lin Y, Chen R, Tang J, Yu C, Wu JL, Chen L, Chang S. Machine-Learning Monitoring System for Predicting Mortality Among Patients With Noncancer End-Stage Liver Disease: Retrospective Study (Preprint).. [DOI: 10.2196/preprints.24305] [Reference Citation Analysis]
132 Mahgoub S, Armstrong MJ, Ferguson JW. Editorial: current challenges in predicting mortality in patients with cirrhosis and refractory ascites. Aliment Pharmacol Ther 2020;52:885-6. [PMID: 32852822 DOI: 10.1111/apt.15982] [Reference Citation Analysis]
133 Lai JC, Dodge JL, Kappus MR, Dunn MA, Volk ML, Duarte-Rojo A, Ganger DR, Rahimi RS, McCulloch CE, Haugen CE, McAdams-DeMarco M, Ladner DP, Segev DL, Verna EC; Multi-Center Functional Assessment in Liver Transplantation (FrAILT) Study. Changes in frailty are associated with waitlist mortality in patients with cirrhosis. J Hepatol 2020;73:575-81. [PMID: 32240717 DOI: 10.1016/j.jhep.2020.03.029] [Cited by in Crossref: 47] [Cited by in F6Publishing: 44] [Article Influence: 15.7] [Reference Citation Analysis]
134 Yoon U, Topper J, Goldhammer J. Preoperative Evaluation and Anesthetic Management of Patients With Liver Cirrhosis Undergoing Cardiac Surgery. J Cardiothorac Vasc Anesth 2020:S1053-0770(20)30816-8. [PMID: 32891522 DOI: 10.1053/j.jvca.2020.08.022] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
135 Praktiknjo M, Clees C, Pigliacelli A, Fischer S, Jansen C, Lehmann J, Pohlmann A, Lattanzi B, Krabbe VK, Strassburg CP, Arroyo V, Merli M, Meyer C, Trebicka J. Sarcopenia Is Associated With Development of Acute-on-Chronic Liver Failure in Decompensated Liver Cirrhosis Receiving Transjugular Intrahepatic Portosystemic Shunt. Clin Transl Gastroenterol 2019;10:e00025. [PMID: 30939488 DOI: 10.14309/ctg.0000000000000025] [Cited by in Crossref: 45] [Cited by in F6Publishing: 47] [Article Influence: 15.0] [Reference Citation Analysis]
136 Saeki C, Kanai T, Nakano M, Oikawa T, Torisu Y, Abo M, Saruta M, Tsubota A. Relationship between Osteosarcopenia and Frailty in Patients with Chronic Liver Disease. J Clin Med 2020;9:E2381. [PMID: 32722566 DOI: 10.3390/jcm9082381] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
137 Nishikawa H, Enomoto H, Nishiguchi S, Iijima H. Liver Cirrhosis and Sarcopenia from the Viewpoint of Dysbiosis. Int J Mol Sci. 2020;21:5254. [PMID: 32722100 DOI: 10.3390/ijms21155254] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
138 Haugen CE, McAdams-DeMarco M, Verna EC, Rahimi RS, Kappus MR, Dunn MA, Volk ML, Gurakar A, Duarte-Rojo A, Ganger DR, O'Leary JG, Ladner D, Garonzik-Wang J, Segev DL, Lai JC. Association Between Liver Transplant Wait-list Mortality and Frailty Based on Body Mass Index. JAMA Surg 2019;154:1103-9. [PMID: 31509169 DOI: 10.1001/jamasurg.2019.2845] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 7.7] [Reference Citation Analysis]
139 San Martín-Valenzuela C, Borras-Barrachina A, Gallego JJ, Urios A, Mestre-Salvador V, Correa-Ghisays P, Ballester MP, Escudero-García D, Tosca J, Montón C, Ríos MP, Kosenko E, Felipo V, Tabares-Seisdedos R, Selva-Vera G, Montoliu C. Motor and Cognitive Performance in Patients with Liver Cirrhosis with Minimal Hepatic Encephalopathy. J Clin Med 2020;9:E2154. [PMID: 32650464 DOI: 10.3390/jcm9072154] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
140 Fozouni L, Lai JC. Frailty as an Immune-Mediated Condition That Leads to an Increased Risk of Acute Cellular Rejection in Liver Transplant Recipients. Clin Liver Dis (Hoboken) 2020;15:243-5. [PMID: 32617158 DOI: 10.1002/cld.960] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
141 Haugen CE, McAdams-DeMarco M, Holscher CM, Ying H, Gurakar AO, Garonzik-Wang J, Cameron AM, Segev DL, Lai JC. Multicenter Study of Age, Frailty, and Waitlist Mortality Among Liver Transplant Candidates. Ann Surg 2020;271:1132-6. [PMID: 30672803 DOI: 10.1097/SLA.0000000000003207] [Cited by in Crossref: 32] [Cited by in F6Publishing: 36] [Article Influence: 10.7] [Reference Citation Analysis]
142 Tapper EB, Wexler R, Goldman E, Volk M. Constitutional Challenges to Liver Transplant Policy. Transplantation 2019;103:e378-81. [PMID: 31259856 DOI: 10.1097/TP.0000000000002703] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
143 Kuo SZ, Ahmad M, Dunn MA, Montano-Loza AJ, Carey EJ, Lin S, Moghe A, Chen HW, Ebadi M, Lai JC. Sarcopenia Predicts Post-transplant Mortality in Acutely Ill Men Undergoing Urgent Evaluation and Liver Transplantation. Transplantation 2019;103:2312-7. [PMID: 30985575 DOI: 10.1097/TP.0000000000002741] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 8.0] [Reference Citation Analysis]
144 Salim TI, Nestlerode LC, Lucatorto EL, Wasserman TL, Din HA, Landsittel DP, Tevar AD, Johnson JT, Duarte-Rojo A, Dunn MA. Frailty as Tested by Gait Speed Is a Risk Factor for Liver Transplant Respiratory Complications. Am J Gastroenterol 2020;115:859-66. [PMID: 32235146 DOI: 10.14309/ajg.0000000000000609] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 5.3] [Reference Citation Analysis]
145 Nishikawa H, Yoh K, Enomoto H, Iwata Y, Sakai Y, Kishino K, Shimono Y, Ikeda N, Takashima T, Aizawa N, Takata R, Hasegawa K, Koriyama T, Yuri Y, Nishimura T, Nishiguchi S, Iijima H. Serum Zinc Level Is Associated with Frailty in Chronic Liver Diseases. J Clin Med 2020;9:E1570. [PMID: 32455875 DOI: 10.3390/jcm9051570] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
146 Rachakonda V, Argemi J, Borhani AA, Bataller R, Tevar A, Behari J. Reduced Serum Sphingolipids Constitute a Molecular Signature of Malnutrition in Hospitalized Patients With Decompensated Cirrhosis. Clin Transl Gastroenterol 2019;10:e00013. [PMID: 30908309 DOI: 10.14309/ctg.0000000000000013] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
147 Deng Y, Lin L, Fan X, Cui B, Hou L, Zhao T, Hou J, Mao L, Wang X, Zhao W, Wang B, Yu Q, Sun C. Incorporation of frailty estimated by gait speed within MELD-Na and the predictive potential for mortality in cirrhosis. Ther Adv Chronic Dis 2020;11:2040622320922023. [PMID: 32489574 DOI: 10.1177/2040622320922023] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
148 Panchangam C, White DA, Goudar S, Birnbaum B, Malloy-Walton L, Gross-Toalson J, Reid KJ, Shirali G, Parthiban A. Translation of the Frailty Paradigm from Older Adults to Children with Cardiac Disease. Pediatr Cardiol 2020;41:1031-41. [PMID: 32377892 DOI: 10.1007/s00246-020-02354-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
149 Chen HW, Ferrando AA, Dunn MA, Kim WR, Duarte-Rojo A. Cadence From Physical Activity Trackers for Monitoring of Home-Based Exercise Intensity in Advanced Liver Disease. Liver Transpl 2020;26:718-21. [PMID: 32145132 DOI: 10.1002/lt.25745] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
150 Wiering L, Öllinger R, Kruppa J, Schoeneberg U, Dziodzio T, Jara M, Biebl M, Dargie R, Raschzok N, Schöning W, Eurich D, Schmelzle M, Sauer IM, Pratschke J, Ritschl PV. Hospitalization Before Liver Transplantation Predicts Posttransplant Patient Survival: A Propensity Score-Matched Analysis. Liver Transpl 2020;26:628-39. [PMID: 32159923 DOI: 10.1002/lt.25748] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
151 Dunn MA, Rogal SS, Duarte-Rojo A, Lai JC. Physical Function, Physical Activity, and Quality of Life After Liver Transplantation. Liver Transpl 2020;26:702-8. [PMID: 32128971 DOI: 10.1002/lt.25742] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 12.3] [Reference Citation Analysis]
152 Asrani SK, Jennings LW, Kim WR, Kamath PS, Levitsky J, Nadim MK, Testa G, Leise MD, Trotter JF, Klintmalm G. MELD-GRAIL-Na: Glomerular Filtration Rate and Mortality on Liver-Transplant Waiting List. Hepatology 2020;71:1766-74. [PMID: 31523825 DOI: 10.1002/hep.30932] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 7.3] [Reference Citation Analysis]
153 Maurice J, Pinzani M. The stratification of cirrhosis. Hepatol Res 2020;50:535-41. [PMID: 32072721 DOI: 10.1111/hepr.13493] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 3.7] [Reference Citation Analysis]
154 Zucchelli A, Marengoni A, Rizzuto D, Calderón-Larrañaga A, Zucchelli M, Bernabei R, Onder G, Fratiglioni L, Vetrano DL. Using a genetic algorithm to derive a highly predictive and context-specific frailty index. Aging (Albany NY) 2020;12:7561-75. [PMID: 32343260 DOI: 10.18632/aging.103118] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
155 Dhaliwal A, Williams FR, El-sherif O, Armstrong MJ. Sarcopenia in Liver Transplantation: an Update. Curr Hepatology Rep 2020;19:128-37. [DOI: 10.1007/s11901-020-00515-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
156 Salim T, Stark SA, Duarte-rojo A. Food as Therapy for Frailty. Curr Hepatology Rep 2020;19:23-9. [DOI: 10.1007/s11901-020-00509-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
157 Fozouni L, Mohamad Y, Lebsack A, Freise C, Stock P, Lai JC. Frailty Is Associated With Increased Rates of Acute Cellular Rejection Within 3 Months After Liver Transplantation. Liver Transpl 2020;26:390-6. [PMID: 31655014 DOI: 10.1002/lt.25669] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
158 Hirota K, Kawaguchi T, Koya S, Nagamatsu A, Tomita M, Hashida R, Nakano D, Niizeki T, Matsuse H, Shiba N, Torimura T. Clinical utility of the Liver Frailty Index for predicting muscle atrophy in chronic liver disease patients with hepatocellular carcinoma. Hepatol Res 2020;50:330-41. [PMID: 31721387 DOI: 10.1111/hepr.13453] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]
159 Kennett AR, Olson JC. Nutrition Management in the Critically Ill Patient with Cirrhosis. Curr Hepatology Rep 2020;19:30-39. [DOI: 10.1007/s11901-020-00506-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
160 El Sherif O, Dhaliwal A, Newsome PN, Armstrong MJ. Sarcopenia in nonalcoholic fatty liver disease: new challenges for clinical practice. Expert Rev Gastroenterol Hepatol 2020;14:197-205. [PMID: 32064966 DOI: 10.1080/17474124.2020.1731303] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
161 Wan SZ, Nie Y, Zhang Y, Liu C, Zhu X. Assessing the Prognostic Performance of the Child-Pugh, Model for End-Stage Liver Disease, and Albumin-Bilirubin Scores in Patients with Decompensated Cirrhosis: A Large Asian Cohort from Gastroenterology Department. Dis Markers 2020;2020:5193028. [PMID: 32148566 DOI: 10.1155/2020/5193028] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
162 Federico A, Caprio GG, Dalise AM, Barbieri M, Dallio M, Loguercio C, Paolisso G, Rizzo MR. Cirrhosis and frailty assessment in elderly patients: A paradoxical result. Medicine (Baltimore) 2020;99:e18501. [PMID: 31914020 DOI: 10.1097/MD.0000000000018501] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
163 Pazniokas J, Gandhi C, Theriault B, Schmidt M, Cole C, Al-Mufti F, Santarelli J, Bowers CA. The immense heterogeneity of frailty in neurosurgery: a systematic literature review. Neurosurg Rev 2021;44:189-201. [PMID: 31953785 DOI: 10.1007/s10143-020-01241-2] [Cited by in Crossref: 28] [Cited by in F6Publishing: 19] [Article Influence: 9.3] [Reference Citation Analysis]
164 Buchard B, Boirie Y, Cassagnes L, Lamblin G, Coilly A, Abergel A. Assessment of Malnutrition, Sarcopenia and Frailty in Patients with Cirrhosis: Which Tools Should We Use in Clinical Practice? Nutrients. 2020;12:186. [PMID: 31936597 DOI: 10.3390/nu12010186] [Cited by in Crossref: 37] [Cited by in F6Publishing: 39] [Article Influence: 12.3] [Reference Citation Analysis]
165 Tapper EB. Deciphering the Cirrhotic Patient’s Present Status: The Overlap Between Physical Frailty, Disability, and Sarcopenia. Frailty and Sarcopenia in Cirrhosis 2020. [DOI: 10.1007/978-3-030-26226-6_3] [Reference Citation Analysis]
166 Choudhary NS, Sonavane A, Saraf N, Saigal S, Rastogi A, Bhangui P, Thiagrajan S, Yadav SK, Saha S, Soin AS. Poor Performance Status Predicts Mortality After Living Donor Liver Transplantation. J Clin Exp Hepatol 2020;10:37-42. [PMID: 32025165 DOI: 10.1016/j.jceh.2019.06.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
167 Merli M, Lattanzi B, D’ambrosio D, Fabrini N, Liguori A. Nutritional Therapy in the Management of Physical Frailty and Sarcopenia. Frailty and Sarcopenia in Cirrhosis 2020. [DOI: 10.1007/978-3-030-26226-6_6] [Reference Citation Analysis]
168 Kappus MR, Barman P. Muscle Mass Versus Muscle Strength and Performance: Is Muscle Mass Measurement Alone Enough? Frailty and Sarcopenia in Cirrhosis 2020. [DOI: 10.1007/978-3-030-26226-6_9] [Reference Citation Analysis]
169 Purdy GM, Riess KJ, Ismond KP, Tandon P. Exercise Training in Patients with Cirrhosis. Frailty and Sarcopenia in Cirrhosis 2020. [DOI: 10.1007/978-3-030-26226-6_7] [Reference Citation Analysis]
170 Dasarathy S. The Pathogenesis of Physical Frailty and Sarcopenia. Frailty and Sarcopenia in Cirrhosis 2020. [DOI: 10.1007/978-3-030-26226-6_4] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
171 Dunn MA. A Research Wish List to Understand, Diagnose, and Manage Frailty and Sarcopenia. Frailty and Sarcopenia in Cirrhosis 2020. [DOI: 10.1007/978-3-030-26226-6_18] [Reference Citation Analysis]
172 Bhanji RA, Carey EJ. Physical Frailty and Sarcopenia in End-Stage Liver Disease: Do They Improve After Liver Transplantation? Frailty and Sarcopenia in Cirrhosis 2020. [DOI: 10.1007/978-3-030-26226-6_13] [Reference Citation Analysis]
173 Buettner S, Ijzermans JNM, van Vugt JLA. Prognostic Implications of Physical Frailty and Sarcopenia Pre and Post Transplantation. Frailty and Sarcopenia in Cirrhosis 2020. [DOI: 10.1007/978-3-030-26226-6_5] [Reference Citation Analysis]
174 Bunchorntavakul C, Reddy KR. Review article: malnutrition/sarcopenia and frailty in patients with cirrhosis. Aliment Pharmacol Ther 2020;51:64-77. [PMID: 31701570 DOI: 10.1111/apt.15571] [Cited by in Crossref: 68] [Cited by in F6Publishing: 66] [Article Influence: 22.7] [Reference Citation Analysis]
175 Wu T, Sundaram V. Obesity and the Critically Ill Cirrhotic Patient. The Critically Ill Cirrhotic Patient 2020. [DOI: 10.1007/978-3-030-24490-3_8] [Reference Citation Analysis]
176 Chen H, Duarte-rojo A. The Definition and Diagnosis of Frailty in the Research and Clinical Settings. Frailty and Sarcopenia in Cirrhosis 2020. [DOI: 10.1007/978-3-030-26226-6_2] [Reference Citation Analysis]
177 Mahmud N, Goldberg DS. Declining predictive performance of the MELD: Cause for concern or reflection of changes in clinical practice? Am J Transplant 2019;19:3221-2. [PMID: 31553133 DOI: 10.1111/ajt.15606] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
178 Tapper EB, Derstine B, Baki J, Su GL. Bedside Measures of Frailty and Cognitive Function Correlate with Sarcopenia in Patients with Cirrhosis. Dig Dis Sci 2019;64:3652-9. [PMID: 31292783 DOI: 10.1007/s10620-019-05713-4] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]
179 Hanai T, Shiraki M, Imai K, Suetsugu A, Takai K, Moriwaki H, Shimizu M. Reduced handgrip strength is predictive of poor survival among patients with liver cirrhosis: A sex-stratified analysis. Hepatol Res 2019;49:1414-26. [PMID: 31408558 DOI: 10.1111/hepr.13420] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 6.8] [Reference Citation Analysis]
180 Labenz C. Prognose bei Leberzirrhose. Gastro-News 2019;6:23-24. [DOI: 10.1007/s15036-019-0686-1] [Reference Citation Analysis]
181 Ravikiran SK, Bhat M. Editorial: effect of exercise on physical frailty in patients with chronic liver disease. Aliment Pharmacol Ther 2019;50:1241-2. [PMID: 31709608 DOI: 10.1111/apt.15534] [Reference Citation Analysis]
182 DeMaria S Jr, Khromava M, Schiano TD, Lin HM, Kim S. Standardized measures of frailty predict hospital length of stay following orthotopic liver transplantation for hepatocellular carcinoma. Clin Transplant 2019;33:e13746. [PMID: 31664734 DOI: 10.1111/ctr.13746] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
183 Raveh Y, Livingstone J, Mahan J, Tekin A, Selvaggi G, Bowdon‐romero M, Nicolau‐raducu R. Comprehensive Frailty Severity Index for End‐Stage Liver Disease Predicts Early Outcomes After Liver Transplantation. Journal of Parenteral and Enteral Nutrition 2020;44:1079-88. [DOI: 10.1002/jpen.1729] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
184 Williams FR, Berzigotti A, Lord JM, Lai JC, Armstrong MJ. Review article: impact of exercise on physical frailty in patients with chronic liver disease. Aliment Pharmacol Ther 2019;50:988-1000. [PMID: 31502264 DOI: 10.1111/apt.15491] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 11.0] [Reference Citation Analysis]
185 Becchetti C, Bosch J. Muscle abnormalities in cirrhosis: Calling for more strength in evaluation and prevention. Dig Liver Dis 2019;51:1500-1. [PMID: 31542219 DOI: 10.1016/j.dld.2019.08.015] [Reference Citation Analysis]
186 Aby ES, Saab S. Frailty, Sarcopenia, and Malnutrition in Cirrhotic Patients. Clin Liver Dis 2019;23:589-605. [PMID: 31563213 DOI: 10.1016/j.cld.2019.06.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
187 Lai JC, Dodge JL, McCulloch CE, Covinsky KE, Singer JP. Frailty and the Burden of Concurrent and Incident Disability in Patients With Cirrhosis: A Prospective Cohort Study. Hepatol Commun 2020;4:126-33. [PMID: 31909360 DOI: 10.1002/hep4.1444] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 4.8] [Reference Citation Analysis]
188 Sinclair M. Controversies in Diagnosing Sarcopenia in Cirrhosis-Moving from Research to Clinical Practice. Nutrients. 2019;11:2454. [PMID: 31615103 DOI: 10.3390/nu11102454] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
189 Van Jacobs AC. Frailty Assessment in Patients with Liver Cirrhosis. Clin Liver Dis (Hoboken) 2019;14:121-5. [PMID: 31632663 DOI: 10.1002/cld.825] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
190 Mouzaki M, Bronsky J, Gupte G, Hojsak I, Jahnel J, Pai N, Quiros-Tejeira RE, Wieman R, Sundaram S. Nutrition Support of Children With Chronic Liver Diseases: A Joint Position Paper of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr 2019;69:498-511. [PMID: 31436707 DOI: 10.1097/MPG.0000000000002443] [Cited by in Crossref: 38] [Cited by in F6Publishing: 28] [Article Influence: 9.5] [Reference Citation Analysis]
191 Agbim U, Asrani SK. The Path Chosen Matters for Patients With Cirrhosis and the Acute Kidney Injury to Chronic Kidney Disease Continuum. Clin Gastroenterol Hepatol 2019;17:2182-4. [PMID: 31004757 DOI: 10.1016/j.cgh.2019.04.030] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
192 Haque L, Palumbo CS, Batisti J. PRO: Older Adults Should Be Offered Liver Transplantation. Clin Liver Dis (Hoboken) 2019;14:66-9. [PMID: 31508223 DOI: 10.1002/cld.821] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
193 Kalra A, Kriss M, Francis P, Norvell JP. CON: Patients of Advanced Age Should Not Routinely Undergo Liver Transplantation. Clin Liver Dis (Hoboken) 2019;14:70-3. [PMID: 31508224 DOI: 10.1002/cld.818] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
194 Knoop V, Costenoble A, Vella Azzopardi R, Vermeiren S, Debain A, Jansen B, Scafoglieri A, Bautmans I; Gerontopole Brussels Study group. The operationalization of fatigue in frailty scales: a systematic review. Ageing Res Rev 2019;53:100911. [PMID: 31136819 DOI: 10.1016/j.arr.2019.100911] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
195 Campisi J, Kapahi P, Lithgow GJ, Melov S, Newman JC, Verdin E. From discoveries in ageing research to therapeutics for healthy ageing. Nature 2019;571:183-92. [PMID: 31292558 DOI: 10.1038/s41586-019-1365-2] [Cited by in Crossref: 397] [Cited by in F6Publishing: 415] [Article Influence: 99.3] [Reference Citation Analysis]
196 Lai JC, Sonnenday CJ, Tapper EB, Duarte-Rojo A, Dunn MA, Bernal W, Carey EJ, Dasarathy S, Kamath BM, Kappus MR, Montano-Loza AJ, Nagai S, Tandon P. Frailty in liver transplantation: An expert opinion statement from the American Society of Transplantation Liver and Intestinal Community of Practice. Am J Transplant 2019;19:1896-906. [PMID: 30980701 DOI: 10.1111/ajt.15392] [Cited by in Crossref: 66] [Cited by in F6Publishing: 67] [Article Influence: 16.5] [Reference Citation Analysis]
197 Wang CW, Lebsack A, Chau S, Lai JC. The Range and Reproducibility of the Liver Frailty Index. Liver Transpl 2019;25:841-7. [PMID: 30884128 DOI: 10.1002/lt.25449] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 8.5] [Reference Citation Analysis]
198 Thuluvath PJ, Hanish S, Savva Y. Waiting List Mortality and Transplant Rates for NASH Cirrhosis When Compared With Cryptogenic, Alcoholic, or AIH Cirrhosis. Transplantation. 2019;103:113-121. [PMID: 29985186 DOI: 10.1097/tp.0000000000002355] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 4.8] [Reference Citation Analysis]
199 High KP, Zieman S, Gurwitz J, Hill C, Lai J, Robinson T, Schonberg M, Whitson H. Use of Functional Assessment to Define Therapeutic Goals and Treatment. J Am Geriatr Soc 2019;67:1782-90. [PMID: 31081938 DOI: 10.1111/jgs.15975] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
200 Essam Behiry M, Mogawer S, Yamany A, Rakha M, Awad R, Emad N, Abdelfatah Y. Ability of the Short Physical Performance Battery Frailty Index to Predict Mortality and Hospital Readmission in Patients with Liver Cirrhosis. Int J Hepatol 2019;2019:8092865. [PMID: 31186966 DOI: 10.1155/2019/8092865] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
201 Lai JC, Rahimi RS, Verna EC, Kappus MR, Dunn MA, McAdams-DeMarco M, Haugen CE, Volk ML, Duarte-Rojo A, Ganger DR, O'Leary JG, Dodge JL, Ladner D, Segev DL. Frailty Associated With Waitlist Mortality Independent of Ascites and Hepatic Encephalopathy in a Multicenter Study. Gastroenterology 2019;156:1675-82. [PMID: 30668935 DOI: 10.1053/j.gastro.2019.01.028] [Cited by in Crossref: 107] [Cited by in F6Publishing: 106] [Article Influence: 26.8] [Reference Citation Analysis]
202 Perito ER, Bucuvalas J, Lai JC. Functional status at listing predicts waitlist and posttransplant mortality in pediatric liver transplant candidates. Am J Transplant 2019;19:1388-96. [PMID: 30506640 DOI: 10.1111/ajt.15203] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
203 Kobashigawa J, Dadhania D, Bhorade S, Adey D, Berger J, Bhat G, Budev M, Duarte-Rojo A, Dunn M, Hall S, Harhay MN, Johansen KL, Joseph S, Kennedy CC, Kransdorf E, Lentine KL, Lynch RJ, McAdams-DeMarco M, Nagai S, Olymbios M, Patel J, Pinney S, Schaenman J, Segev DL, Shah P, Singer LG, Singer JP, Sonnenday C, Tandon P, Tapper E, Tullius SG, Wilson M, Zamora M, Lai JC. Report from the American Society of Transplantation on frailty in solid organ transplantation. Am J Transplant 2019;19:984-94. [PMID: 30506632 DOI: 10.1111/ajt.15198] [Cited by in Crossref: 113] [Cited by in F6Publishing: 117] [Article Influence: 28.3] [Reference Citation Analysis]
204 Tapper EB, Baki J, Parikh ND, Lok AS. Frailty, Psychoactive Medications, and Cognitive Dysfunction Are Associated With Poor Patient-Reported Outcomes in Cirrhosis. Hepatology 2019;69:1676-85. [PMID: 30382584 DOI: 10.1002/hep.30336] [Cited by in Crossref: 38] [Cited by in F6Publishing: 25] [Article Influence: 9.5] [Reference Citation Analysis]
205 Gilbo N, Jochmans I, Sainz-Barriga M, Nevens F, van der Merwe S, Laleman W, Verslype C, Cassiman D, Verbeke L, van Malenstein H, Roskams T, Pirenne J, Monbaliu D. Age Matching of Elderly Liver Grafts With Elderly Recipients Does Not Have a Synergistic Effect on Long-term Outcomes When Both Are Carefully Selected. Transplant Direct 2019;5:e342. [PMID: 30993187 DOI: 10.1097/TXD.0000000000000883] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
206 Loftus TJ, Brown MP, Slish JH, Rosenthal MD. Serum Levels of Prealbumin and Albumin for Preoperative Risk Stratification. Nutrition in Clinical Practice 2019;34:340-8. [DOI: 10.1002/ncp.10271] [Cited by in Crossref: 35] [Cited by in F6Publishing: 40] [Article Influence: 8.8] [Reference Citation Analysis]
207 Román E, Nieto JC, Gely C, Vidal S, Pozuelo M, Poca M, Juárez C, Guarner C, Manichanh C, Soriano G. Effect of a Multistrain Probiotic on Cognitive Function and Risk of Falls in Patients With Cirrhosis: A Randomized Trial. Hepatol Commun 2019;3:632-45. [PMID: 31061952 DOI: 10.1002/hep4.1325] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 8.0] [Reference Citation Analysis]
208 Bhanji RA, Takahashi N, Moynagh MR, Narayanan P, Angirekula M, Mara KC, Dierkhising RA, Watt KD. The evolution and impact of sarcopenia pre- and post-liver transplantation. Aliment Pharmacol Ther 2019;49:807-13. [PMID: 30714184 DOI: 10.1111/apt.15161] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 8.8] [Reference Citation Analysis]
209 Johansen KL. Metrics of Aging in Transplantation. Curr Transpl Rep 2019;6:36-44. [DOI: 10.1007/s40472-019-0229-x] [Reference Citation Analysis]
210 Rubin JB, Sinclair M, Rahimi RS, Tapper EB, Lai JC. Women on the liver transplantation waitlist are at increased risk of hospitalization compared to men. World J Gastroenterol 2019; 25(8): 980-988 [PMID: 30833803 DOI: 10.3748/wjg.v25.i8.980] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
211 Chiu E, Marr K, Taylor L, Lam L, Stapleton M, Tandon P, Raman M. Malnutrition Impacts Health-Related Quality of Life in Cirrhosis: A Cross-Sectional Study. Nutr Clin Pract 2020;35:119-25. [PMID: 30806489 DOI: 10.1002/ncp.10265] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
212 Montgomery JR, Englesbe MJ. Changes in Frailty Status: Some Better, Some Worse. Transplantation 2019;103:1540-1. [PMID: 30753176 DOI: 10.1097/TP.0000000000002564] [Reference Citation Analysis]
213 Murphy SL, Tapper EB, Blackwood J, Richardson JK. Why Do Individuals with Cirrhosis Fall? A Mechanistic Model for Fall Assessment, Treatment, and Research. Dig Dis Sci 2019;64:316-23. [PMID: 30327964 DOI: 10.1007/s10620-018-5333-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
214 Sinha R. Editorial: moving towards a robust definition of sarcopenia in cirrhosis. Aliment Pharmacol Ther 2019;49:340-1. [PMID: 30663102 DOI: 10.1111/apt.15070] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
215 Tapper EB. Frailty and Outcomes After Liver Transplantation. Curr Transplant Rep 2019;6:1-6. [PMID: 31602355 DOI: 10.1007/s40472-019-0222-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
216 Jacobs AH, Bollheimer C. Frailty. Neurogeriatrie 2019. [DOI: 10.1007/978-3-662-57358-7_5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
217 Artzner T, Michard B, Besch C, Levesque E, Faitot F. Liver transplantation for critically ill cirrhotic patients: Overview and pragmatic proposals. World J Gastroenterol 2018; 24(46): 5203-5214 [PMID: 30581269 DOI: 10.3748/wjg.v24.i46.5203] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
218 Dasarathy S. Myostatin and beyond in cirrhosis: All roads lead to sarcopenia. J Cachexia Sarcopenia Muscle. 2017;8:864-869. [PMID: 29168629 DOI: 10.1002/jcsm.12262] [Cited by in Crossref: 34] [Cited by in F6Publishing: 38] [Article Influence: 6.8] [Reference Citation Analysis]
219 Oloruntoba OO, Moylan CA. "Too Female" for Liver Transplantation. Hepatology 2018;68:2424-5. [PMID: 29679376 DOI: 10.1002/hep.30053] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
220 El-gamal S, El-menshawy HHE, Abbas NF, El-metwally O. Acute kidney injury network criteria as a prognostic factor in cirrhotic patients with spontaneous bacterial peritonitis. Egypt J Intern Med 2018;30:264-270. [DOI: 10.4103/ejim.ejim_15_18] [Reference Citation Analysis]
221 Bernardi M, Caraceni P. Novel perspectives in the management of decompensated cirrhosis. Nat Rev Gastroenterol Hepatol 2018;15:753-64. [PMID: 30026556 DOI: 10.1038/s41575-018-0045-2] [Cited by in Crossref: 40] [Cited by in F6Publishing: 34] [Article Influence: 8.0] [Reference Citation Analysis]
222 Laube R, Wang H, Park L, Heyman JK, Vidot H, Majumdar A, Strasser SI, McCaughan GW, Liu K. Frailty in advanced liver disease. Liver Int 2018;38:2117-28. [PMID: 29935102 DOI: 10.1111/liv.13917] [Cited by in Crossref: 52] [Cited by in F6Publishing: 42] [Article Influence: 10.4] [Reference Citation Analysis]
223 Moore C, Stein AC. Assessment and Management of Nutrition Status in the Hospitalized Patient With Cirrhosis. Clin Liver Dis (Hoboken) 2018;12:113-6. [PMID: 30988924 DOI: 10.1002/cld.758] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
224 Tandon P, Ismond KP, Riess K, Duarte-Rojo A, Al-Judaibi B, Dunn MA, Holman J, Howes N, Haykowsky MJF, Josbeno DA, McNeely M. Exercise in cirrhosis: Translating evidence and experience to practice. J Hepatol 2018;69:1164-77. [PMID: 29964066 DOI: 10.1016/j.jhep.2018.06.017] [Cited by in Crossref: 94] [Cited by in F6Publishing: 90] [Article Influence: 18.8] [Reference Citation Analysis]
225 Cullaro G, Park M, Lai JC. "Normal" Creatinine Levels Predict Persistent Kidney Injury and Waitlist Mortality in Outpatients With Cirrhosis. Hepatology 2018;68:1953-60. [PMID: 29698588 DOI: 10.1002/hep.30058] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
226 By the Contributors to the C4 Article (Appendix 1). Current opinions in organ allocation. Am J Transplant 2018;18:2625-34. [PMID: 30303603 DOI: 10.1111/ajt.15094] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
227 Cardona M, Lewis ET, Kristensen MR, Skjøt-Arkil H, Ekmann AA, Nygaard HH, Jensen JJ, Jensen RO, Pedersen JL, Turner RM, Garden F, Alkhouri H, Asha S, Mackenzie J, Perkins M, Suri S, Holdgate A, Winoto L, Chang DCW, Gallego-Luxan B, McCarthy S, Petersen JA, Jensen BN, Backer Mogensen C, Hillman K, Brabrand M. Predictive validity of the CriSTAL tool for short-term mortality in older people presenting at Emergency Departments: a prospective study. Eur Geriatr Med 2018;9:891-901. [PMID: 30574216 DOI: 10.1007/s41999-018-0123-6] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 5.2] [Reference Citation Analysis]
228 Peng JK, Hepgul N, Higginson IJ, Gao W. Symptom prevalence and quality of life of patients with end-stage liver disease: A systematic review and meta-analysis. Palliat Med 2019;33:24-36. [PMID: 30345878 DOI: 10.1177/0269216318807051] [Cited by in Crossref: 89] [Cited by in F6Publishing: 95] [Article Influence: 17.8] [Reference Citation Analysis]
229 Li M, Zhao Y, Liu X, Dang Z, Wang X, Jiang Y, Yang Z. Association and interaction between model for end-stage liver disease score and minimally invasive treatment with regard to mortality of patients with hepatitis B virus-associated hepatocellular carcinoma and portal vein tumor thrombi. Oncol Lett 2019;17:119-26. [PMID: 30655746 DOI: 10.3892/ol.2018.9590] [Reference Citation Analysis]
230 Bajaj JS, Moreau R, Kamath PS, Vargas HE, Arroyo V, Reddy KR, Szabo G, Tandon P, Olson J, Karvellas C, Gustot T, Lai JC, Wong F. Acute-on-Chronic Liver Failure: Getting Ready for Prime Time? Hepatology 2018;68:1621-32. [PMID: 29689120 DOI: 10.1002/hep.30056] [Cited by in Crossref: 71] [Cited by in F6Publishing: 56] [Article Influence: 14.2] [Reference Citation Analysis]
231 Tapper EB, Konerman M, Murphy S, Sonnenday CJ. Hepatic encephalopathy impacts the predictive value of the Fried Frailty Index. Am J Transplant 2018;18:2566-70. [PMID: 30019835 DOI: 10.1111/ajt.15020] [Cited by in Crossref: 40] [Cited by in F6Publishing: 39] [Article Influence: 8.0] [Reference Citation Analysis]
232 Hayashi M, Abe K, Fujita M, Okai K, Takahashi A, Ohira H. Association between sarcopenia and osteoporosis in chronic liver disease. Hepatol Res 2018;48:893-904. [PMID: 29734510 DOI: 10.1111/hepr.13192] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 5.4] [Reference Citation Analysis]
233 Ney M, Tangri N, Dobbs B, Bajaj J, Rolfson D, Ma M, Ferguson T, Bhardwaj P, Bailey RJ, Abraldes J, Tandon P. Predicting Hepatic Encephalopathy-Related Hospitalizations Using a Composite Assessment of Cognitive Impairment and Frailty in 355 Patients With Cirrhosis. Am J Gastroenterol 2018;113:1506-15. [PMID: 30267028 DOI: 10.1038/s41395-018-0243-0] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 5.0] [Reference Citation Analysis]
234 Kuo SZ, Lizaola B, Hayssen H, Lai JC. Beta-blockers and physical frailty in patients with end-stage liver disease. World J Gastroenterol 2018; 24(33): 3770-3775 [PMID: 30197482 DOI: 10.3748/wjg.v24.i33.3770] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
235 Lai JC, Segev DL, McCulloch CE, Covinsky KE, Dodge JL, Feng S. Physical frailty after liver transplantation. Am J Transplant 2018;18:1986-94. [PMID: 29380529 DOI: 10.1111/ajt.14675] [Cited by in Crossref: 84] [Cited by in F6Publishing: 84] [Article Influence: 16.8] [Reference Citation Analysis]
236 Maddur H, Levitsky J. Frailty after liver transplantation: The strong survive but may not prosper. Am J Transplant 2018;18:1841-2. [PMID: 29603630 DOI: 10.1111/ajt.14750] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
237 Mazzarelli C, Prentice WM, Heneghan MA, Belli LS, Agarwal K, Cannon MD. Palliative care in end-stage liver disease: Time to do better? Liver Transpl 2018;24:961-8. [PMID: 29729119 DOI: 10.1002/lt.25193] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 5.4] [Reference Citation Analysis]
238 Lai JC, Covinsky KE, Dodge JL, Boscardin WJ, Segev DL, Roberts JP, Feng S. Reply. Hepatology 2018;67:2059-60. [PMID: 29377206 DOI: 10.1002/hep.29817] [Reference Citation Analysis]
239 Fan H, Zhu JH. A novel frailty index improves risk prediction of waitlist mortality over the model for end-stage liver disease score alone. Hepatology 2018;67:2059. [PMID: 29377211 DOI: 10.1002/hep.29813] [Reference Citation Analysis]
240 Linecker M, Krones T, Berg T, Niemann CU, Steadman RH, Dutkowski P, Clavien PA, Busuttil RW, Truog RD, Petrowsky H. Potentially inappropriate liver transplantation in the era of the "sickest first" policy - A search for the upper limits. J Hepatol 2018;68:798-813. [PMID: 29133246 DOI: 10.1016/j.jhep.2017.11.008] [Cited by in Crossref: 50] [Cited by in F6Publishing: 46] [Article Influence: 10.0] [Reference Citation Analysis]
241 Kok B, Tandon P. Frailty in Patients With Cirrhosis. Curr Treat Options Gastroenterol. 2018;16:215-225. [PMID: 29589278 DOI: 10.1007/s11938-018-0179-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
242 Kahn J, Wagner D, Homfeld N, Müller H, Kniepeiss D, Schemmer P. Both sarcopenia and frailty determine suitability of patients for liver transplantation-A systematic review and meta-analysis of the literature. Clin Transplant 2018;32:e13226. [DOI: 10.1111/ctr.13226] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 6.4] [Reference Citation Analysis]
243 Chen HW, Dunn MA. Arresting frailty and sarcopenia in cirrhosis: Future prospects. Clin Liver Dis (Hoboken) 2018;11:52-7. [PMID: 30992788 DOI: 10.1002/cld.691] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
244 Lai JC, Covinsky KE, McCulloch CE, Feng S. The Liver Frailty Index Improves Mortality Prediction of the Subjective Clinician Assessment in Patients With Cirrhosis. Am J Gastroenterol 2018;113:235-42. [PMID: 29231189 DOI: 10.1038/ajg.2017.443] [Cited by in Crossref: 81] [Cited by in F6Publishing: 78] [Article Influence: 16.2] [Reference Citation Analysis]
245 Dunn MA. The cost of sarcopenia. Transpl Int 2018;31:155-6. [DOI: 10.1111/tri.13069] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
246 Duarte-Rojo A, Ruiz-Margáin A, Montaño-Loza AJ, Macías-Rodríguez RU, Ferrando A, Kim WR. Exercise and physical activity for patients with end-stage liver disease: Improving functional status and sarcopenia while on the transplant waiting list. Liver Transpl 2018;24:122-39. [PMID: 29024353 DOI: 10.1002/lt.24958] [Cited by in Crossref: 105] [Cited by in F6Publishing: 105] [Article Influence: 21.0] [Reference Citation Analysis]
247 Rana A, Witte ED, Halazun KJ, Sood GK, Mindikoglu AL, Sussman NL, Vierling JM, Kueht ML, Galvan NTN, Cotton RT, O'mahony CA, Goss JA. Liver transplant length of stay (LOS) index: A novel predictive score for hospital length of stay following liver transplantation. Clin Transplant 2017;31:e13141. [DOI: 10.1111/ctr.13141] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 3.2] [Reference Citation Analysis]
248 Choden T, Satoskar R. MELD-Na: Does This Leave Anyone Behind? Curr Hepatology Rep 2017;16:220-227. [DOI: 10.1007/s11901-017-0356-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]